BioStem Technologies Expands Patent Protection for Placental Allograft and Umbilical Tissue Tech

BioStem Technologies has enhanced its patent portfolio with a newly issued U.S. patent and pending allowances in the U.S. and Mexico. These protections cover the company's sterile placental allograft, micronized wound care, and umbilical cord extract technologies.